Issue 44, October 28, 2014

Each Tuesday, to enhance awareness of emerging scientific knowledge, selected science clips will be posted here for the public health community. The focus is applied public health research and prevention science that has the capacity to improve health now.

1. CDC Authored Publications
   The names of CDC authors are indicated in bold text.
   Articles published in the past 6-8 weeks authored by CDC or ATSDR staff.
   • Chronic Diseases and Conditions
     1. Alcohol control efforts in comprehensive cancer control plans and alcohol use among adults in the USA
        Henley SJ, Kanny D, Roland KB, Grossman M, Peaker B, Liu Y, Gapstur SM, White MC, Plescia M.
        Alcohol Alcohol. 2014 Nov;49(6):661-7.
        
     2. Associations between antioxidants and all-cause mortality among US adults with obstructive lung function
        Ford ES, Li C, Cunningham TJ, Croft JB.
        Br J Nutr. 2014 Oct 15:1-12.
        
     3. Tracking psychosocial health in adults with epilepsy-estimates from the 2010 National Health Interview Survey
        Kobau R, Cui W, Kadima N, Zack MM, Sajatovic M, Kaiboriboon K, Jobst B.
        Epilepsy Behav. 2014 Oct 7;41c:66-73.
        
     4. Common pathways toward informing policy and environmental strategies to promote health: a study of CDC's Prevention Research Centers
        Neri EM, Stringer KJ, Spadaro AJ, Ballman MR, Grunbaum JA.
        Health Promot Pract. 2014 Oct 9.
        
     5. Measuring chronic liver disease mortality using an expanded cause of death definition and medical records in Connecticut, 2004
        Ly KN, Speers S, Klevens RM, Barry V, Vogt TM.
        Hepatol Res. 2014 Oct 16.
        
   • Communicable Diseases
     6. Longitudinal analysis of HIV-1-specific antibody responses
        Curtis KA, Kennedy MS, Owen SM.
        AIDS Res Hum Retroviruses. 2014 Oct 14.
        
     7. Acceptability of home self-tests for HIV in New York City, 2006
        Myers JE, Bodach S, Cutler BH, Shepard CW, Philippou C, Branson BM.
        Am J Public Health. 2014 Oct 16:e1-e3.
        
     8. Improving pandemic influenza risk assessment
        Russell CA, Kasson PM, Donis RO, Riley S, Dunbar J, Rambaut A, Asher J, Burke S, Davis CT, Garten RJ, Gnanakaran S, Hay SI, Herfst S, Lewis NS, Lloyd-Smith JO, Macken CA, Maurer-Stroh S, Neuhaus E, Parrish CR, Pepin KM, Shepard SS, Smith DL, Suarez DL, Trock SC, Widdowson MA, et al .
        Elife. 2014 ;3.
        
     9. Climate change and infectious diseases in the Arctic: establishment of a circumpolar working group
        Parkinson AJ, Evengard B, Semenza JC, Ogden N, Borresen ML, Berner J, Brubaker M, Sjostedt A, Evander M, Hondula DM, Menne B, Pshenichnaya N, Gounder P, et al .
        Int J Circumpolar Health. 2014 ;73.
        
     10. Maintaining polio-free certification in the World Health Organization Western Pacific Region for over a decade
         Adams A, Boualam L, Diorditsa S, Gregory C, Jee Y, Mendoza-Aldana J, Roesel S.
         J Infect Dis. 2014 Nov 1;210 Suppl 1:S259-67.
         
     11. Progress toward poliomyelitis eradication in Nigeria
         Ado JM, Etsano A, Shuaib F, Damisa E, Mkanda P, Gasasira A, Banda R, Korir C, Johnson T, Dieng B, Corkum M, Enemaku O, Mataruse N, Ohuabunwo C, Baig S, Galway M, Seaman V, Wiesen E, Vertefeuille J, Ogbuanu IU, Armstrong G, Mahoney FJ.
         J Infect Dis. 2014 Nov 1;210 Suppl 1:S40-9.
         
     12. Progress and peril: poliomyelitis eradication efforts in Pakistan, 1994-2013
         Alexander JP, Zubair M, Khan M, Abid N, Durry E.
         J Infect Dis. 2014 Nov 1;210 Suppl 1:S152-61.
         
     13. Factors contributing to outbreaks of wild poliovirus type 1 infection involving persons aged >/=15 years in the Democratic Republic of the Congo, 2010-2011, informed by a pre-outbreak poliovirus immunity assessment
         Alleman MM, Wannemuehler KA, Weldon WC, Kabuayi JP, Ekofo F, Edidi S, Mulumba A, Mbule A, Ntumbannji RN, Coulibaly T, Abiola N, Mpingulu M, Sidibe K, Oberste MS.
         J Infect Dis. 2014 Nov 1;210 Suppl 1:S62-73.
         
     14. Improved acute flaccid paralysis surveillance performance in the Democratic Republic of the Congo, 2010-2012
         Alleman MM, Meyer SA, Mulumba A, Nyembwe M, Riziki Y, Mbule A, Mayenga M, Coulibaly T.
         J Infect Dis. 2014 Nov 1;210 Suppl 1:S50-61.
         
     15. Environmental surveillance for polioviruses in the Global Polio Eradication Initiative
         Asghar H, Diop OM, Weldegebriel G, Malik F, Shetty S, El Bassioni L, Akande AO, Al Maamoun E, Zaidi S, Adeniji AJ, Burns CC, Deshpande J, Oberste MS, Lowther SA.
         J Infect Dis. 2014 Nov 1;210 Suppl 1:S294-303.
         
     16. Global Polio Eradication Initiative: lessons learned and legacy
         Cochi SL, Freeman A, Guirguis S, Jafari H, Aylward B.
         J Infect Dis. 2014 Nov 1;210 Suppl 1:S540-6.
         
     17. A world without polio
         Cochi SL, Jafari HS, Armstrong GL, Sutter RW, Linkins RW, Pallansch MA, Kew O, Aylward RB.
         J Infect Dis. 2014 Nov 1;210 Suppl 1:S1-4.
         
     18. Phylogeny of imported and reestablished wild polioviruses in the Democratic Republic of the Congo from 2006 to 2011
         Gumede N, Jorba J, Deshpande J, Pallansch M, Yogolelo R, Muyembe-Tamfum JJ, Kew O, Venter M, Burns CC.
         J Infect Dis. 2014 Nov 1;210 Suppl 1:S361-7.
         
     19. Polio outbreak investigation and response in Somalia, 2013
         Kamadjeu R, Mahamud A, Webeck J, Baranyikwa MT, Chatterjee A, Bile YN, Birungi J, Mbaeyi C, Mulugeta A.
         J Infect Dis. 2014 Nov 1;210 Suppl 1:S181-6.
         
     20. Challenges of maintaining polio-free status of the European region
         Khetsuriani N, Pfeifer D, Deshevoi S, Gavrilin E, Shefer A, Butler R, Jankovic D, Spataru R, Emiroglu N, Martin R.
         J Infect Dis. 2014 Nov 1;210 Suppl 1:S194-207.
         
     21. Individual-based modeling of potential poliovirus transmission in connected religious communities in North America with low uptake of vaccination
         Kisjes KH, Duintjer Tebbens RJ, Wallace GS, Pallansch MA, Cochi SL, Wassilak SG, Thompson KM.
         J Infect Dis. 2014 Nov 1;210 Suppl 1:S424-33.
         
     22. Polio eradication in the World Health Organization African Region, 2008-2012
         Kretsinger K, Gasasira A, Poy A, Porter KA, Everts J, Salla M, Brown KH, Wassilak SG, Nshimirimana D.
         J Infect Dis. 2014 Nov 1;210 Suppl 1:S23-39.
         
     23. Outbreaks of paralytic poliomyelitis during 1996-2012: the changing epidemiology of a disease in the final stages of eradication
         Mach O, Tangermann RH, Wassilak SG, Singh S, Sutter RW.
         J Infect Dis. 2014 Nov 1;210 Suppl 1:S275-82.
         
     24. Prevalence of asymptomatic poliovirus infection in older children and adults in northern India: analysis of contact and enhanced community surveillance, 2009
         Mach O, Verma H, Khandait DW, Sutter RW, O'Connor PM, Pallansch MA, Cochi SL, Linkins RW, Chu SY, et al .
         J Infect Dis. 2014 Nov 1;210 Suppl 1:S252-8.
         
     25. Progress toward polio eradication-Somalia, 1998-2013
         Mbaeyi C, Kamadjeu R, Mahamud A, Webeck J, Ehrhardt D, Mulugeta A.
         J Infect Dis. 2014 Nov 1;210 Suppl 1:S173-80.
         
     26. Progress in the development of poliovirus antiviral agents and their essential role in reducing risks that threaten eradication
         McKinlay MA, Collett MS, Hincks JR, Oberste MS, Pallansch MA, Okayasu H, Sutter RW, Modlin JF, Dowdle WR.
         J Infect Dis. 2014 Nov 1;210 Suppl 1:S447-53.
         
     27. Simulation exercises to strengthen polio outbreak preparedness: experience of the World Health Organization European Region
         Moulsdale HJ, Khetsuriani N, Deshevoi S, Butler R, Simpson J, Salisbury D.
         J Infect Dis. 2014 Nov 1;210 Suppl 1:S208-15.
         
     28. Cluster lot quality assurance sampling: effect of increasing the number of clusters on classification precision and operational feasibility
         Okayasu H, Brown AE, Nzioki MM, Gasasira AN, Takane M, Mkanda P, Wassilak SG, Sutter RW.
         J Infect Dis. 2014 Nov 1;210 Suppl 1:S341-6.
         
     29. Polio eradication initiative in Afghanistan, 1997-2013
         Simpson DM, Sadr-Azodi N, Mashal T, Sabawoon W, Pardis A, Quddus A, Garrigos C, Guirguis S, Zahoor Zaidi SS, Shaukat S, Sharif S, Asghar H, Hadler SC.
         J Infect Dis. 2014 Nov 1;210 Suppl 1:S162-72.
         
     30. Progress toward global interruption of wild poliovirus transmission, 2010-2013, and tackling the challenges to complete eradication
         Wassilak SG, Oberste MS, Tangermann RH, Diop OM, Jafari HS, Armstrong GL.
         J Infect Dis. 2014 Nov 1;210 Suppl 1:S5-s15.
         
     31. Outbreak of type 1 wild poliovirus infection in adults, Namibia, 2006
         Yusuf N, de Wee R, Foster N, Watkins MA, Tiruneh D, Chauvin C, Bossarte R, Mandlhate C, Jack A, Gumede N, Mawela A, Burns CC, Pallansch MA, Allies T, Rainey J, et al .
         J Infect Dis. 2014 Nov 1;210 Suppl 1:S353-60.
         
     32. Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial
         Baeten JM, Donnell D, Mugo NR, Ndase P, Thomas KK, Campbell JD, Wangisi J, Tappero JW, et al .
         Lancet Infect Dis. 2014 Oct 6.
         
     33. HIV, hepatitis B virus, and hepatitis C virus co-infection in patients in the China National Free Antiretroviral Treatment Program, 2010-12: a retrospective observational cohort study
         Zhang F, Zhu H, Wu Y, Dou Z, Zhang Y, Kleinman N, Bulterys M, et al .
         Lancet Infect Dis. 2014 Oct 7.
         
     34. Surveillance and preparedness for Ebola virus disease - New York City, 2014
         Benowitz I, Ackelsberg J, Balter SE, Baumgartner JC, Dentinger C, Fine AD, Harper SA, Jones LE, Laraque F, Lee EH, Merizalde G, Quinn C, Slavinski S, Winters AI, Weiss D, Yacisin KA, et al .
         MMWR Morb Mortal Wkly Rep. 2014 Oct 17;63(41):934-6.
         
     35. Cluster of Ebola cases among Liberian and U.S. health care workers in an Ebola treatment unit and adjacent hospital - Liberia, 2014
         Forrester JD, Hunter JC, Pillai SK, Arwady MA, Ayscue P, Matanock A, Monroe B, Schafer IJ, Nyenswah TG, De Cock KM.
         MMWR Morb Mortal Wkly Rep. 2014 Oct 17;63(41):925-9.
         
     36. Notes from the field: increase in gonorrhea cases in counties associated with American Indian reservations - Montana, January 2012-August 2014
         Nett RJ, Choi P, Murolo C, Murphy JS.
         MMWR Morb Mortal Wkly Rep. 2014 Oct 17;63(41):937.
         
     37. Developing an incident management system to support Ebola response - Liberia, July-August 2014
         Pillai SK, Nyenswah T, Rouse E, Arwady MA, Forrester JD, Hunter JC, Matanock A, Ayscue P, Monroe B, Schafer IJ, Poblano L, Neatherlin J, Montgomery JM, De Cock KM.
         MMWR Morb Mortal Wkly Rep. 2014 Oct 17;63(41):930-3.
         
     38. PCR-based national bacterial meningitis surveillance in Turkey years 2006 to 2009
         Toprak D, Soysal A, Torunoglu MA, Turgut M, Turkoglu S, Pimenta FC, Carvalho MD, et al .
         Pediatr Infect Dis J. 2014 Oct;33(10):1087-1089.
         
   • Drug Safety
     39. Falsified medicines in Africa: all talk, no action
         Newton PN, Tabernero P, Dwivedi P, Culzoni MJ, Monge ME, Swamidoss I, Mildenhall D, Green MD, et al .
         Lancet Glob Health. 2014 Sep;2(9):e509-10.
         
   • Food Safety
     40. Historical and current perspectives on Clostridium botulinum diversity
         Smith TJ, Hill KK, Raphael BH.
         Res Microbiol. 2014 Oct 10.
         
   • Genetics and Genomics
     41. Comparative genomic analysis of genogroup 1 (Wa-like) rotaviruses circulating in the USA, 2006-2009
         Roy S, Esona MD, Kirkness EF, Akopov A, Kyle McAllen J, Wikswo M, Cortese MM, Payne DC, Parashar U, Gentsch JR, Bowen MD.
         Infect Genet Evol. 2014 Oct 6.
         
   • Healthcare Economics
     42. Cost of informal caregiving associated with stroke among the elderly in the United States
         Joo H, Dunet DO, Fang J, Wang G.
         Neurology. 2014 Oct 10.
         
   • Immunity and Immunization
     43. Adult vaccination disparities among foreign-born populations in the U.S., 2012
         Lu PJ, Rodriguez-Lainz A, O'Halloran A, Greby S, Williams WW.
         Am J Prev Med. 2014 Oct 6.
         
     44. Pertactin-negative B. pertussis strains: evidence for a possible selective advantage
         Martin SW, Pawloski L, Williams M, Weening K, DeBolt C, Qin X, Reynolds L, Kenyon C, Giambrone G, Kudish K, Miller L, Selvage D, Lee A, Skoff TH, Kamiya H, Cassiday PK, Tondella ML, Clark TA.
         Clin Infect Dis. 2014 Oct 9.
         
     45. Strengthening the partnership between routine immunization and the Global Polio Eradication Initiative to achieve eradication and assure sustainability
         Abdelwahab J, Dietz V, Eggers R, Maher C, Olaniran M, Sandhu H, Vandelaer J.
         J Infect Dis. 2014 Nov 1;210 Suppl 1:S498-503.
         
     46. Estimating the likely coverage of inactivated poliovirus vaccine in routine immunization: evidence from demographic and health surveys
         Anand A, Pallansch MA, Estivariz CF, Gary H, Wassilak SG.
         J Infect Dis. 2014 Nov 1;210 Suppl 1:S465-74.
         
     47. An acute flaccid paralysis surveillance-based serosurvey of poliovirus antibodies in Western Uttar Pradesh, India
         Bahl S, Gary HE, Jafari H, Sarkar BK, Pathyarch SK, Sethi R, Deshpande J.
         J Infect Dis. 2014 Nov 1;210 Suppl 1:S234-42.
         
     48. Cross-sectional serologic assessment of immunity to poliovirus infection in high-risk areas of northern India
         Bahl S, Estivariz CF, Sutter RW, Sarkar BK, Verma H, Jain V, Agrawal A, Rathee M, Shukla H, Pathyarch SK, Sethi R, Wannemuehler KA, Jafari H, Deshpande JM.
         J Infect Dis. 2014 Nov 1;210 Suppl 1:S243-51.
         
     49. Vaccine-derived polioviruses
         Burns CC, Diop OM, Sutter RW, Kew OM.
         J Infect Dis. 2014 Nov 1;210 Suppl 1:S283-93.
         
     50. Poliovirus immunity among pregnant females aged 15-44 years, Namibia, 2010
         Cardemil CV, Jonas A, Gerber S, Weldon WC, Oberste MS, Beukes A, Sawadogo S, Patel SV, Zeko S, Muroua C, Gaeb E, Wannemuehler K, Goodson JL.
         J Infect Dis. 2014 Nov 1;210 Suppl 1:S136-42.
         
     51. Effect of buffer on the immune response to trivalent oral poliovirus vaccine in Bangladesh: a community based randomized controlled trial
         Chandir S, Ahamed KU, Baqui AH, Sutter RW, Okayasu H, Pallansch MA, Oberste MS, et al .
         J Infect Dis. 2014 Nov 1;210 Suppl 1:S390-7.
         
     52. Assessing population immunity in a persistently high-risk area for wild poliovirus transmission in India: a serological study in Moradabad, western Uttar Pradesh
         Deshpande JM, Bahl S, Sarkar BK, Estivariz CF, Sharma S, Wolff C, Sethi R, Pathyarch SK, Jain V, Gary HE, Pallansch MA, Jafari H.
         J Infect Dis. 2014 Nov 1;210 Suppl 1:S225-33.
         
     53. Introduction of sequential inactivated polio vaccine-oral polio vaccine schedule for routine infant immunization in Brazil's National Immunization Program
         Domingues CM, de Fatima Pereira S, Cunha Marreiros AC, Menezes N, Flannery B.
         J Infect Dis. 2014 Nov 1;210 Suppl 1:S143-51.
         
     54. Limitations of using administratively reported immunization data for monitoring routine immunization system performance in Nigeria
         Dunkle SE, Wallace AS, MacNeil A, Mustafa M, Gasasira A, Ali D, Elmousaad H, Mahoney F, Sandhu HS.
         J Infect Dis. 2014 Nov 1;210 Suppl 1:S523-30.
         
     55. Detection of vaccine-derived polioviruses in Mexico using environmental surveillance
         Esteves-Jaramillo A, Estivariz CF, Penaranda S, Richardson VL, Reyna J, Coronel DL, Carrion V, Landaverde JM, Wassilak SG, Perez-Sanchez EE, Lopez-Martinez I, Burns CC, Pallansch MA.
         J Infect Dis. 2014 Nov 1;210 Suppl 1:S315-23.
         
     56. An evaluation of polio supplemental immunization activities in Kano, Katsina, and Zamfara states, Nigeria: lessons in progress
         Gammino VM, Nuhu A, Gerber S, Gasasira A, Sugerman DE, Manneh F, Chenoweth P, Kurnit MR, Abanida EA.
         J Infect Dis. 2014 Nov 1;210 Suppl 1:S91-7.
         
     57. Outreach to underserved communities in northern Nigeria, 2012-2013
         Gidado SO, Ohuabunwo C, Nguku PM, Ogbuanu IU, Waziri NE, Biya O, Wiesen ES, Mba-Jonas A, Vertefeuille J, Oyemakinde A, Nwanyanwu O, Lawal N, Mahmud M, Nasidi A, Mahoney FJ.
         J Infect Dis. 2014 Nov 1;210 Suppl 1:S118-24.
         
     58. Effectiveness of oral polio vaccination against paralytic poliomyelitis: a matched case-control study in Somalia
         Mahamud A, Kamadjeu R, Webeck J, Mbaeyi C, Baranyikwa MT, Birungi J, Nurbile Y, Ehrhardt D, et al .
         J Infect Dis. 2014 Nov 1;210 Suppl 1:S187-93.
         
     59. An assessment of the reasons for oral poliovirus vaccine refusals in northern Nigeria
         Michael CA, Ogbuanu IU, Storms AD, Ohuabunwo CJ, Corkum M, Ashenafi S, Achari P, Biya O, Nguku P, Mahoney F.
         J Infect Dis. 2014 Nov 1;210 Suppl 1:S125-30.
         
     60. An evaluation of community perspectives and contributing factors to missed children during an oral polio vaccination campaign - Katsina state, Nigeria
         Michael CA, Ashenafi S, Ogbuanu IU, Ohuabunwo C, Sule A, Corkum M, Mackay S, Storms AD, Achari P, Biya O, Nguku P, Newberry D, Bwaka A, Mahoney F.
         J Infect Dis. 2014 Nov 1;210 Suppl 1:S131-5.
         
     61. Vaccine-associated paralytic poliomyelitis: a review of the epidemiology and estimation of the global burden
         Platt LR, Estivariz CF, Sutter RW.
         J Infect Dis. 2014 Nov 1;210 Suppl 1:S380-9.
         
     62. Screening for long-term poliovirus excretion among children with primary immunodeficiency disorders: preparation for the polio posteradication era in Bangladesh
         Sazzad HM, Rainey JJ, Kahn AL, Mach O, Liyanage JB, Alam AN, Kawser CA, et al .
         J Infect Dis. 2014 Nov 1;210 Suppl 1:S373-9.
         
     63. Switch from oral to inactivated poliovirus vaccine in Yogyakarta province, Indonesia: summary of coverage, immunity, and environmental surveillance
         Wahjuhono G, Revolusiana , Widhiastuti D, Sundoro J, Mardani T, Ratih WU, Sutomo R, Safitri I, Sampurno OD, Rana B, Roivainen M, Kahn AL, Mach O, Pallansch MA, Sutter RW.
         J Infect Dis. 2014 Nov 1;210 Suppl 1:S347-52.
         
     64. Forewarning of poliovirus outbreaks in the horn of Africa: an assessment of acute flaccid paralysis surveillance and routine immunization systems in Kenya
         Walker AT, Sodha S, Warren WC, Sergon K, Kiptoon S, Ogange J, Ahmeda AH, Eshetu M, Corkum M, Pillai S, Scobie H, Mdodo R, Tack DM, Halldin C, Appelgren K, Kretsinger K, Bensyl DM, et al .
         J Infect Dis. 2014 Nov 1;210 Suppl 1:S85-90.
         
     65. Overview of global, regional, and national routine vaccination coverage trends and growth patterns from 1980 to 2009: implications for vaccine-preventable disease eradication and elimination initiatives
         Wallace AS, Ryman TK, Dietz V.
         J Infect Dis. 2014 Nov 1;210 Suppl 1:S514-22.
         
     66. Polio eradication in Nigeria and the role of the National Stop Transmission of Polio Program, 2012-2013
         Waziri NE, Ohuabunwo CJ, Nguku PM, Ogbuanu IU, Gidado S, Biya O, Wiesen ES, Vertefeuille J, Townes D, Oyemakinde A, Nwanyanwu O, Gassasira A, Mkanda P, Muhammad AJ, Elmousaad HA, Nasidi A, Mahoney FJ.
         J Infect Dis. 2014 Nov 1;210 Suppl 1:S111-7.
         
     67. Factors associated with uptake of the influenza A(H1N1)pdm09 monovalent pandemic vaccine in K-12 public schools, Maine 2009-2010
         Lorick SA, Goldberg L, Zhang F, Birkhimer N, Dube N, Dutram K, Hubley T, Tipton M, Basurto-Davila R, Graitcer S, Mills DA.
         J Public Health Manag Pract. 2014 Oct 9.
         
     68. Effectiveness of monovalent human rotavirus vaccine against admission to hospital for acute rotavirus diarrhoea in South African children: a case-control study
         Groome MJ, Page N, Cortese MM, Moyes J, Zar HJ, Kapongo CN, Mulligan C, Diedericks R, Cohen C, Fleming JA, Seheri M, Mphahlele J, Walaza S, Khan K, Chhagan M, Steele AD, Parashar UD, et al .
         Lancet Infect Dis. 2014 Oct 7.
         
     69. Vaccination coverage among children in kindergarten - United States, 2013-14 school year
         Seither R, Masalovich S, Knighton CL, Mellerson J, Singleton JA, Greby SM.
         MMWR Morb Mortal Wkly Rep. 2014 Oct 17;63(41):913-20.
         
     70. Narcolepsy and influenza A(H1N1) pandemic 2009 vaccination in the United States
         Duffy J, Weintraub E, Vellozzi C, DeStefano F.
         Neurology. 2014 Oct 15.
         
     71. A qualitative study of vaccine acceptability and decision making among pregnant women in Morocco during the A (H1N1) pdm09 pandemic
         Lohiniva AL, Barakat A, Dueger E, Restrepo S, El Aouad R.
         PLoS One. 2014 ;9(10):e96244.
         
     72. The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG)
         Chen RT, Carbery B, Mac L, Berns KI, Chapman L, Condit RC, Excler JL, Gurwith M, Hendry M, et al .
         Vaccine. 2014 Oct 8.
         
   • Informatics
     73. Using geographic information systems to track polio vaccination team performance: pilot project report
         Gammino VM, Nuhu A, Chenoweth P, Manneh F, Young RR, Sugerman DE, Gerber S, et al .
         J Infect Dis. 2014 Nov 1;210 Suppl 1:S98-s101.
         
   • Injury and Violence
     74. Childhood adversity and adult chronic disease: an update from ten states and the District of Columbia, 2010
         Gilbert LK, Breiding MJ, Merrick MT, Thompson WW, Ford DC, Dhingra SS, Parks SE.
         Am J Prev Med. 2014 Oct 6.
         
     75. Longitudinal associations among bully, homophobic teasing, and sexual violence perpetration among middle school students
         Espelage DL, Basile KC, De La Rue L, Hamburger ME.
         J Interpers Violence. 2014 Oct 13.
         
   • Laboratory Sciences
     76. Viremic control is independent of repeated low-dose SHIV exposures
         Henning TR, Hanson D, Vishwanathan SA, Butler K, Dobard C, Garcia-Lerma G, Radzio J, Smith J, McNicholl JM, Kersh EN.
         AIDS Res Hum Retroviruses. 2014 Oct 14.
         
     77. The stability of hexacosanoyl lysophosphatidylcholine in dried-blood spot quality control materials for X-linked adrenoleukodystrophy newborn screening
         Haynes CA, De Jesus VR.
         Clin Biochem. 2014 Oct 11.
         
     78. Tenofovir disoproxil fumarate intravaginal ring protects high dose depot medroxyprogesterone acetate treated macaques from multiple SHIV exposures
         Smith JM, Srinivasan P, Teller RS, Lo Y, Dinh CT, Kiser PF, Herold BC.
         J Acquir Immune Defic Syndr. 2014 Oct 15.
         
     79. Evaluation of dried blood spots collected on filter papers from three manufacturers stored at ambient temperature for application in HIV-1 drug resistance monitoring
         Rottinghaus EK, Beard RS, Bile E, Modukanele M, Maruping M, Mine M, Nkengasong J, Yang C.
         PLoS One. 2014 ;9(10):e109060.
         
   • Maternal and Child Health
     80. Functional difficulties and school limitations of children with epilepsy: findings from the 2009-2010 National Survey of Children with Special Health Care Needs
         Pastor PN, Reuben CA, Kobau R, Helmers SL, Lukacs S.
         Disabil Health J. 2014 Sep 16.
         
     81. Antihistamines and birth defects: a systematic review of the literature
         Gilboa SM, Ailes EC, Rai RP, Anderson JA, Honein MA.
         Expert Opin Drug Saf. 2014 Oct 11:1-32.
         
     82. Long term outcomes in children with congenital heart disease: National Health Interview Survey
         Razzaghi H, Oster M, Reefhuis J.
         J Pediatr. 2014 Oct 8.
         
     83. Prenatal bisphenol A exposure and maternally reported behavior in boys and girls
         Evans SF, Kobrosly RW, Barrett ES, Thurston SW, Calafat AM, Weiss B, Stahlhut R, et al .
         Neurotoxicology. 2014 Oct 9.
         
   • Occupational Safety and Health
     84. Understanding the hospital sharps injury reporting pathway
         Boden LI, Petrofsky YV, Hopcia K, Wagner GR, Hashimoto D.
         Am J Ind Med. 2014 Oct 10.
         
     85. Evaluation of the pulmonary toxicity of a fume generated from a nickel-, copper-based electrode to be used as a substitute in stainless steel welding
         Antonini JM, Badding MA, Meighan TG, Keane M, Leonard SS, Roberts JR.
         Environ Health Insights. 2014 10/15;8(Suppl. 1):11-20.
         
     86. Youth on racial minority operated U.S. farms, 2008: demographics and injuries
         Hendricks KJ.
         J Saf Res. 2014 ;51:81-86.
         
     87. Biomechanical risk factors for carpal tunnel syndrome: a pooled study of 2474 workers
         Harris-Adamson C, Eisen EA, Kapellusch J, Garg A, Hegmann KT, Thiese MS, Dale AM, Evanoff B, Burt S, et al .
         Occup Environ Med. 2014 Oct 16.
         
     88. Health and safety management systems through a multilevel and strategic management perspective: theoretical and empirical considerations
         Yorio P, Willmer D, Moore S.
         Saf Sci. 2014 ;72:221-228.
         
   • Parasitic Diseases
     89. Ocular toxoplasmosis in the United States: recent and remote infections
         Jones JL, Bonetti V, Holland GN, Press C, Sanislo SR, Khurana RN, Montoya JG.
         Clin Infect Dis. 2014 Oct 9.
         
   • Physical Activity
     90. Understanding municipal officials' involvement in transportation policies supportive of walking and bicycling
         Zwald ML, Eyler AA, Goins KV, Brownson RC, Schmid TL, Lemon SC.
         J Public Health Manag Pract. 2014 Oct 14.
         
   • Program Evaluation
     91. An overview of measurement activities in the partnership for patients
         Hackbarth AD, Munier WB, Eldridge N, Jordan J, Richards C, Brennan NJ, Wagner D, McGann P.
         J Patient Saf. 2014 Sep;10(3):125-32.
         
   • Public Health Law
     92. Evaluation design of New York City's regulations on nutrition, physical activity, and screen time in early child care centers
         Breck A, Goodman K, Dunn L, Stephens RL, Dawkins N, Dixon B, Jernigan J, Kakietek J, Lesesne C, Lessard L, Nonas C, O'Dell SA, Osuji TA, Bronson B, Xu Y, Kettel Khan L.
         Prev Chronic Dis. 2014 ;11:E184.
         
     93. Compliance with New York City's beverage regulations and beverage consumption among children in early child care centers
         Kakietek J, Osuji TA, O'Dell SA, Breck A, Kettel Khan L.
         Prev Chronic Dis. 2014 ;11:E180.
         
     94. Training and technical assistance for compliance with beverage and physical activity components of New York City's regulations for early child care centers
         Kakietek J, Dunn L, O'Dell SA, Jernigan J, Kettel Khan L.
         Prev Chronic Dis. 2014 ;11:E177.
         
     95. Measurement of compliance with New York City's regulations on beverages, physical activity, and screen time in early child care centers
         Lessard L, Lesesne C, Kakietek J, Breck A, Jernigan J, Dunn L, Nonas C, O'Dell SA, Stephens RL, Xu Y, Kettel Khan L.
         Prev Chronic Dis. 2014 ;11:E183.
         
     96. Insights and implications for health departments from the evaluation of New York City's regulations on nutrition, physical activity, and screen time in child care centers
         Nonas C, Silver LD, Kettel Khan L.
         Prev Chronic Dis. 2014 ;11:E178.
         
     97. Rationale for New York City's regulations on nutrition, physical activity, and screen time in early child care centers
         Nonas C, Silver LD, Kettel Khan L, Leviton L.
         Prev Chronic Dis. 2014 ;11:E182.
         
     98. Neighborhood disparities in prevalence of childhood obesity among low-income children before and after implementation of New York City child care regulations
         Sekhobo JP, Edmunds LS, Dalenius K, Jernigan J, Davis CF, Giddings M, Lesesne C, Kettel Khan L.
         Prev Chronic Dis. 2014 ;11:E181.
         
     99. Relationship between child care centers' compliance with physical activity regulations and children's physical activity, New York City, 2010
         Stephens RL, Xu Y, Lesesne CA, Dunn L, Kakietek J, Jernigan J, Khan LK.
         Prev Chronic Dis. 2014 ;11:E179.
         
   • Substance Use and Abuse
     100. Cigarette smoke cadmium breakthrough from traditional filters: implications for exposure
          Pappas RS, Fresquez MR, Watson CH.
          J Anal Toxicol. 2014 Oct 13.
          
     101. Decreasing trend in tobacco-related cancer incidence, United States 2005-2009
          Underwood JM, Richards TB, Henley SJ, Momin B, Houston K, Rolle I, Holmes C, Stewart SL.
          J Community Health. 2014 Oct 10.
          
     102. Estimation of cigarette smoking-attributable morbidity in the United States
          Rostron BL, Chang CM, Pechacek TF.
          JAMA Intern Med. 2014 Oct 13.
          
     103. Increases in smoking cessation interventions after a feedback and improvement initiative using electronic health records - 19 community health centers, New York City, October 2010-March 2012
          Silfen SL, Farley SM, Shih SC, Duquaine DC, Ricci JM, Kansagra SM, Edwards SM, Babb S, McAfee T.
          MMWR Morb Mortal Wkly Rep. 2014 Oct 17;63(41):921-4.
          
   • Zoonoses
     104. Novel poxvirus infection in two patients from the United States
          Osadebe LU, Manthiram K, McCollum AM, Li Y, Emerson GL, Gallardo-Romero NF, Doty JB, Wilkins K, Zhao H, Drew CP, Metcalfe MG, Goldsmith CS, Muehlenbachs A, Googe P, Dunn J, Duenckel T, Henderson H, Carroll DS, Zaki SR, Denison M, Reynolds MG, Damon IK.
          Clin Infect Dis. 2014 Oct 9.
          
     105. Prioritizing zoonoses: a proposed one health tool for collaborative decision-making
          Rist CL, Arriola CS, Rubin C.
          PLoS One. 2014 ;9(10):e109986.
          
     106. Chikungunya virus: new risk to transfusion safety in the Americas
          Petersen LR, Epstein JS.
          Transfusion. 2014 Aug;54(8):1911-5.
          
   
   
2. Key Scientific Articles in Featured Topic Areas
   Subject matter experts decide what topic to feature, and articles are selected from the last 3 to 6 months of published literature. Key topic coincides monthly with other CDC products (e.g. Vital Signs).
   • Chronic Diseases and Conditions - Breast Cancer
     107. Association of skirt size and postmenopausal breast cancer risk in older women: a cohort study within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
          Fourkala EO, Burnell M, Cox C, Ryan A, Salter LC, Gentry-Maharaj A, Parmar M, et al .
          BMJ Open. 2014 ;4(9):e005400.
          
     108. Overdetection in breast cancer screening: development and preliminary evaluation of a decision aid
          Hersch J, Jansen J, Barratt A, Irwig L, Houssami N, Jacklyn G, Thornton H, et al .
          BMJ Open. 2014 ;4(9):e006016.
          
     109. Digital compared to screen-film mammography: breast cancer prognostic features in an organized screening program
          Prummel MV, Done SJ, Muradali D, Majpruz V, Brown P, Jiang H, Shumak RS, et al .
          Breast Cancer Res Treat. 2014 Sep;147(2):389-99.
          
     110. National Breast and Cervical Cancer Early Detection Program data validation project
          Eheman CR, Leadbetter S, Benard VB, Blythe Ryerson A, Royalty JE, Blackman D, Pollack LA, et al .
          Cancer. 2014 Aug 15;120 Suppl 16:2597-603.
          
     111. Cost of services provided by the National Breast and Cervical Cancer Early Detection Program
          Ekwueme DU, Subramanian S, Trogdon JG, Miller JW, Royalty JE, Li C, Guy GP, et al .
          Cancer. 2014 Aug 15;120 Suppl 16:2604-11.
          
     112. From cancer screening to treatment: service delivery and referral in the National Breast and Cervical Cancer Early Detection Program
          Miller JW, Hanson V, Johnson GD, Royalty JE, Richardson LC.
          Cancer. 2014 Aug 15;120 Suppl 16:2549-56.
          
     113. Barriers to breast cancer screening in Australia: experiences of women with physical disabilities
          Peters K, Cotton A.
          J Clin Nurs. 2014 Sep 19.
          
     114. Pan-Canadian study of mammography screening and mortality from breast cancer
          Coldman A, Phillips N, Wilson C, Decker K, Chiarelli AM, Brisson J, Zhang B, et al .
          J Natl Cancer Inst. 2014 Nov;106(11).
          
     115. Effects of screening and systemic adjuvant therapy on ER-specific US breast cancer mortality
          Munoz D, Near AM, van Ravesteyn NT, Lee SJ, Schechter CB, Alagoz O, Berry DA, et al .
          J Natl Cancer Inst. 2014 Nov;106(11).
          
     116. Understanding patient options, utilization patterns, and burdens associated with breast cancer screening
          Harvey SC, Vegesna A, Mass S, Clarke J, Skoufalos A.
          J Womens Health (Larchmt). 2014 Sep;23 Suppl 1:S3-9.
          
     117. Breast cancer screening programmes: challenging the coexistence with opportunistic mammography
          Ouedraogo S, Dabakuyo-Yonli TS, Amiel P, Dancourt V, Dumas A, Arveux P.
          Patient Educ Couns. 2014 Sep 18.
          
     118. Preventing breast cancer in LMICs via screening and/or early detection: the real and the surreal
          Dey S.
          World J Clin Oncol. 2014 Aug 10;5(3):509-19.
          
   
   

Back to Top

____

DISCLAIMER: Articles listed in the CDC Science Clips are selected by the Stephen B. Thacker CDC Library to provide current awareness of the public health literature. An article's inclusion does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the Clips, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.